J. Curtis Nickel, MD, FRCSC provides a compelling case for saw palmetto and why clinicians should not overlook its benefits. His insights are in response to a recent 3-part review published by Stephen B. Strum, MD, FACP, on the effectiveness of saw palmetto around the globe over the past 40 years. Source: Urology Times
Read More »In an interview at the SupplySide West trade show in Las Vegas, Valensa CEO Umasudan (Uma) Pal., noted that while the astaxanthin market has experienced growth over the last decade, “even golden-egg-laying geese can inadvertently be slaughtered.” To learn more about this antioxidant powerhouse, quality and consumer benefits read the entire article.
Read More »Prostate Health and a Standardized Lipidosterolic Extract of Saw Palmetto By Margaret H. Dohnalek, PhD, Chief Science Officer, Valensa International Controversy exists regarding whether or not saw palmetto products support prostate health and related lower urinary tract symptoms (LUTS), such as the urge to urinate, frequent urination, and waking up at night to urinate. These […]
Read More »Astaxanthin for Healthy Aging Astaxanthin is arguably the most powerful antioxidant on Earth. With oxidative stress and inflammation being at the core of the aging cascade,1 balancing physiological processes at the cellular level that deliver oxidative balance and anti-inflammatory activity are the unlocks for cardiovascular, joint, vision and skin health. Today, 52 million Americans are ages […]
Read More »From Supply Chain to Science – Get to Know Saw Palmetto Extract for Prostate Health Natural Products Insider hosts a 50-minute webinar with Valensa’s own Uma Pal, CEO; Margaret H. Dohnalek, PhD, Chief Science Officer; and Larry McCarty, SVP of Production and Supply Chain. In the webinar, learn how USPlus®, a lipidosterolic saw palmetto extract supports […]
Read More »Latest Science Re-Confirms Anti-inflammatory Role of Zanthin, FlexPro MD Valensa’s Science team answered a reporter’s question about inflammation ingredient studies, published between 2000-2020, which have particular impact on healthy aging. Here’s their response: Valensa International continues to be at the forefront of nutraceutical companies by looking at ways to expand our portfolio’s impact on inflammatory […]
Read More »Valensa’s Integrated Supply Chain Capabilities for Continuity of Your Business For Valensa, the value of investing in a fully integrated supply chain begins with ownership of our astaxanthin production facility in South America and the partnership with our sister company in India for spirulina, chlorella and phycocyanin supply. We go beyond ownership of production to […]
Read More »The Next Generation of Prostate Health Supplements – Consistency, Quality, and Trust in One Being first can be both challenging and very rewarding. At Valensa International, we have been a pioneer in production and process improvements to create the highest quality, unique, and patented saw palmetto extract in the world. Today, we are proud to […]
Read More »Valensa Leads Astaxanthin Industry By Partnering Man and Nature Extracting the most powerful antioxidant on earth from a natural source is, not surprisingly, quite a challenge. Adding consistency at high quality standards, like Valensa puts behind Zanthin® Natural Astaxanthin, does not happen overnight. Valensa has gone to great lengths to bring the best, end-to-end solution, […]
Read More »Parry Nutraceuticals Successfully Completes USP’s Rigorous Dietary Ingredient Verification Program to Distinguish Quality of Dietary Ingredients ORLANDO, Fla. (May 22, 2019) — Florida-based Valensa International announces today that its Parry Organic Spirulina, a microalgae-based superfood produced by sister-company, Parry Nutraceuticals, has successfully passed the United States Pharmacopeia’s (USP) voluntary and rigorous Dietary Ingredient Verification Program […]
Read More »